Seagen Inc., formerly Seattle Genetics, Inc. For US residents only. Search In it for life If I could look back to the woman who was scared out of her mind, I would tell her there’s going to be a whole medical community that is going to support you. Don’t be afraid. My perception of metastatic breast cancer has definitely changed. I really feel like there is hope for the future. Julie G. Living with breast cancer See More Stories Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives. Our Mission In it for innovation As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumors and blood-related cancers. Our Science In it to change lives We’re driven by a singular mission—to make a real difference for people impacted by cancer. Whether through developing novel therapies or supporting advocacy programs, we’re committed to helping patients and their families every step of the way. How We Help I SEE THE GOOD IN EVERY DAY It’s easy when you go through life to focus on some of the negatives and be upset by them. But when you go through something like cancer, you realize that you have to focus on the positive—you have to focus on the good in people and the good in your life. And that’s what I’ve been trying to do. Mike R. Treated for Hodgkin lymphoma In it together Seagen is a global team of scientists, engineers, clinicians, advocates, and innovators with a shared commitment to transforming cancer care. We’re dedicated to creating a culture of integrity, collaboration, and diversity, where your drive will make a difference. Join Us Julia Cochran Protein Chemistry Research Associate III Employee since 2012 RECENT NEWS Press Release 11.19.21 Seagen to Highlight New Data in Advanced Breast Cancer at 2021 San Antonio Breast Cancer Symposium Event 10.28.21 Third Quarter 2021 Financial Results Investor Materials 04.01.21 Seagen’s Proxy Statement and Annual Report Now Available See All News Sign up for updates Receive the latest news about Seagen’s innovations in cancer care. Sign Up Patients and Caregivers Diseases We Study Real Stories Clinical Trials Support and Resources Healthcare Professionals Medical Information Clinical Data Requests Investigator-Sponsored Research Medical Education Grants Site Map Contact Us FAQs Sign up for updates This website is intended for U.S. residents only. ©2021 Seagen Inc. Privacy Policy Terms and Conditions Social Media Terms > Cookie Notification By continuing to browse the site, you agree to accept our use of cookies. For more information, please review our Cookies Policy. Accept